SomaLogic opens their first-ever proteomics grant program to APAC life sciences researchers

Two winners will be awarded 40 human plasma or serum samples to be processed on the SomaScan® Platform at Genomax’s Singapore lab SINGAPORE & BOULDER, Colo. -- SomaLogic, Inc., a global leader in proteomics technology, today announced that it is sponsoring the Genomax Research Grant Award for researchers in Singapore. This effort is SomaLogic’s first grant [...]

Rilas Technologies and MOBILion Systems Announce Partnership to Expand Analytical Offering with High Resolution Ion Mobility

CHADDS FORD, Pa. and WOBURN, Mass. -- Rilas Technologies and MOBILion Systems have announced a strategic partnership that will bring together their expertise and cutting-edge platform to provide new separation capabilities for customers. The partnership aims to expand Rilas Technologies' current Agilent 6545XT Q-TOF instrument by integrating it with the MOBIE High Resolution Ion Mobility (HRIM) Platform from MOBILion [...]

908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer

New tool is built on the JMP statistical software package BOSTON --908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced the release of a data analysis tool that provides a quick and effortless way to analyze and visualize the wealth of data generated by the REBEL at-line [...]

Genemod raises $4.5M to become the central research platform for biopharma companies

The round was co-led by defy.vc and LDV Partners  SEATTLE -- Genemod, a cloud-based workspace collaboration software for biopharma R&D teams, today announced it raised $4.5 million in seed funding, co-led by defy.vc and LDV Partners, with participation from Dolby Family Ventures and Vulcan/Cercano Ventures. In the past year, Genemod has expanded into the biopharma R&D space working [...]

Sartorius announces CFO transition

Rainer Lehmann to step down as Chief Financial Officer later this year; Sartorius commences search process Göttingen -- Sartorius’ Chief Financial Officer Rainer Lehmann will step down from his position by the end of October 2023 to pursue a new opportunity outside the company. The Supervisory Board of Sartorius AG has initiated a search process [...]

Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye

Stanford Medicine researcher recognized for his influential work in cell biology and cancer research SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) announced today that Dr. Jiangbin Ye has received an Agilent Solutions Innovation Research Award (SIRA). The award supports drug discovery and development, research exploration, enhancement, and acceleration. Dr. Ye is an Assistant Professor of Radiation [...]

Dr. Stefan Schmidt new CEO of evitria

Changes are afoot at Swiss company evitria: As of May, Dr. Stefan Schmidt will take over the helm of the company, which specializes in the production of recombinant antibodies for medicine and research. Since 2010, evitria, based in Schlieren near Zurich, has specialized in the production of antibodies and other proteins. Today, evitria, part of a group consisting [...]

Nanologica’s Product within Preparative Chromatography Reaches Quality Requirements

After successfully implementing fine-tuning in production, Nanologica's product now meets the company's own requirements for quality in all evaluated parameters. The company is therefore continuing to formally approve products to be able delivery to customers progressively. ”After making further fine-tunings in one of the production steps, we now have a product that we are satisfied with [...]

Paragraf Acquires CRISPR-Chip Developer Cardea Bio, Accelerating CRISPR QC’s Business Opportunity

Acquisition to deliver significant progress in manufacturing and technology capabilities, and will further propel CRISPR QC's success in the fast growing gene editing market. SAN DIEGO -- Today, CRISPR QC announces that Paragraf, Ltd. has acquired Cardea Bio, the technology platform developer of the CRISPR-Chip - a graphene-based biosensor that powers CRISPR QC’s CRISPR Analytics [...]

CELLINK Unveils Third Generation LUMEN X – The New Standard for DLP Bioprinting

Gothenburg, Sweden – CELLINK, a global leader in bioprinting, today announced the release of the third generation of their LUMEN X™ product – the new standard for benchtop DLP bioprinting. This cutting-edge product boasts a significant improvement in printer resolution, and developments in advanced features including the ability to develop multi-stiffness constructs, microfluidic systems, and a [...]

Access IBO on Knowledge Center